Dr. Rebecca Muntean, M.D

NPI: 1003071598
Total Payments
$24,156
2024 Payments
$1,136
Companies
26
Transactions
244
Medicare Patients
2,266
Medicare Billing
$1.2M

Payment Breakdown by Category

Other$13,850 (57.3%)
Food & Beverage$5,813 (24.1%)
Consulting$2,250 (9.3%)
Travel$2,206 (9.1%)
Education$37.62 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,850 8 57.3%
Food and Beverage $5,813 230 24.1%
Consulting Fee $2,250 1 9.3%
Travel and Lodging $2,206 2 9.1%
Education $37.62 3 0.2%

Top Paying Companies

Company Total Records Latest Year
Janssen Scientific Affairs, LLC $17,023 23 $0 (2024)
Janssen Biotech, Inc. $2,616 17 $0 (2024)
Amgen Inc. $1,422 105 $0 (2024)
PFIZER INC. $568.15 30 $0 (2024)
ABBVIE INC. $542.69 7 $0 (2024)
AstraZeneca Pharmaceuticals LP $435.53 11 $0 (2024)
GlaxoSmithKline, LLC. $318.98 10 $0 (2024)
Lilly USA, LLC $185.37 6 $0 (2023)
Novartis Pharmaceuticals Corporation $179.02 7 $0 (2024)
UCB, Inc. $152.12 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,136 45 Amgen Inc. ($386.57)
2023 $1,151 47 Amgen Inc. ($320.98)
2022 $918.19 33 Amgen Inc. ($193.71)
2021 $690.27 45 Amgen Inc. ($353.04)
2020 $2,523 20 Janssen Biotech, Inc. ($2,325)
2019 $847.24 27 GlaxoSmithKline, LLC. ($180.43)
2018 $1,676 8 Janssen Scientific Affairs, LLC ($1,500)
2017 $15,215 19 Janssen Scientific Affairs, LLC ($15,028)

All Payment Transactions

244 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/23/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $10.16 General
Category: Inflammation
12/20/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $34.71 General
Category: Inflammation/Rare Disease
12/17/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $36.59 General
Category: Inflammation/Rare Disease
11/08/2024 Janssen Scientific Affairs, LLC TREMFYA (Drug) Food and Beverage In-kind items and services $118.73 General
Category: Immunology
10/29/2024 Amgen Inc. Enbrel (Biological), Otezla Food and Beverage In-kind items and services $26.62 General
Category: Inflammation
10/22/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $26.38 General
Category: IMMUNOLOGY
10/18/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $15.61 General
Category: Immunology
10/02/2024 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $19.68 General
Category: Inflammation and Autoimmunity
09/26/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $14.02 General
Category: IMMUNOLOGY
09/25/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $4.20 General
Category: Inflammation
09/20/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $18.75 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/28/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $9.00 General
Category: Inflammation
08/15/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage In-kind items and services $28.14 General
Category: Endocrinology
08/09/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $18.61 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/01/2024 Amgen Inc. Enbrel (Biological), Otezla Food and Beverage In-kind items and services $18.91 General
Category: Inflammation
07/17/2024 Amgen Inc. Enbrel (Biological), Otezla Food and Beverage In-kind items and services $22.90 General
Category: Inflammation
07/11/2024 Fresenius Kabi USA, LLC IDACIO (Biological) Food and Beverage In-kind items and services $21.05 General
Category: Biosimilars
07/10/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $21.57 General
Category: IMMUNOLOGY
07/09/2024 AstraZeneca Pharmaceuticals LP SAPHNELO (Biological) Food and Beverage In-kind items and services $15.58 General
Category: Inflammation and Autoimmunity
06/20/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $28.13 General
Category: LUPUS NEPHRITIS
06/20/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $21.46 General
Category: Inflammation/Rare Disease
06/13/2024 Amgen Inc. Enbrel (Biological) Food and Beverage In-kind items and services $5.89 General
Category: Inflammation
06/12/2024 Janssen Scientific Affairs, LLC TREMFYA (Drug) Food and Beverage In-kind items and services $99.44 General
Category: Immunology
05/22/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $20.63 General
05/16/2024 Amgen Inc. Enbrel (Biological), Otezla Food and Beverage In-kind items and services $20.11 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 384 51,801 $619,594 $290,989
2022 16 531 55,740 $954,437 $348,096
2021 19 858 9,565 $1.2M $454,326
2020 14 493 2,501 $215,973 $73,481
Total Patients
2,266
Total Services
119,607
Medicare Billing
$1.2M
Procedure Codes
61

All Medicare Procedures & Services

61 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J3262 Injection, tocilizumab, 1 mg Office 2023 13 50,810 $400,880 $234,976 58.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 161 274 $141,110 $35,088 24.9%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 53 145 $26,825 $7,389 27.5%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 16 61 $23,058 $6,334 27.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 13 13 $8,216 $2,219 27.0%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 16 83 $6,723 $1,856 27.6%
J3489 Injection, zoledronic acid, 1 mg Office 2023 33 165 $3,300 $1,105 33.5%
20610 Aspiration and/or injection of fluid from large joint Office 2023 12 15 $3,273 $872.84 26.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 27 58 $870.00 $487.20 56.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 11 11 $4,195 $344.25 8.2%
96372 Injection of drug or substance under skin or into muscle Office 2023 11 17 $697.00 $191.76 27.5%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2023 18 149 $447.00 $126.30 28.3%
J3262 Injection, tocilizumab, 1 mg Office 2022 12 51,720 $413,760 $235,661 57.0%
J1745 Injection, infliximab, excludes biosimilar, 10 mg Office 2022 12 2,625 $322,875 $54,474 16.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 174 322 $109,802 $27,591 25.1%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2022 57 192 $34,944 $10,323 29.5%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 23 66 $24,354 $6,686 27.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 28 36 $17,316 $4,883 28.2%
96415 Administration of chemotherapy into vein, each additional hour Office 2022 23 84 $6,552 $1,862 28.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 11 11 $6,490 $1,790 27.6%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 18 19 $6,479 $1,467 22.6%
20610 Aspiration and/or injection of fluid from large joint Office 2022 17 22 $4,900 $1,301 26.5%
J3489 Injection, zoledronic acid, 1 mg Office 2022 26 130 $2,600 $597.39 23.0%
96372 Injection of drug or substance under skin or into muscle Office 2022 24 39 $1,482 $439.15 29.6%
96375 Injection of additional new drug or substance into vein Office 2022 14 29 $1,204 $377.78 31.4%

About Dr. Rebecca Muntean, M.D

Dr. Rebecca Muntean, M.D is a Rheumatology healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1003071598.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Muntean, M.D has received a total of $24,156 in payments from pharmaceutical and medical device companies, with $1,136 received in 2024. These payments were reported across 244 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,850).

As a Medicare-enrolled provider, Muntean has provided services to 2,266 Medicare beneficiaries, totaling 119,607 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.

Practice Information

  • Specialty Rheumatology
  • Other Specialties Rheumatology
  • Location Spokane, WA
  • Active Since 07/23/2008
  • Last Updated 03/01/2021
  • Taxonomy Code 207RR0500X
  • Entity Type Individual
  • NPI Number 1003071598

Products in Payments

  • SIMPONI ARIA (Biological) $9,577
  • STELARA (Biological) $7,202
  • TREMFYA (Drug) $2,757
  • Enbrel (Biological) $1,065
  • XELJANZ (Drug) $568.15
  • RINVOQ (Biological) $367.34
  • SAPHNELO (Biological) $347.80
  • BENLYSTA (Biological) $263.35
  • TALTZ (Drug) $169.64
  • PURIFIED CORTROPHIN GEL (Drug) $169.29
  • KRYSTEXXA (Biological) $150.38
  • NATPARA (PARATHYROID HORMONE) (Drug) $124.68
  • COSENTYX (Biological) $116.60
  • Humira (Biological) $100.65
  • SIMPONI (Biological) $95.45
  • TAVNEOS (Drug) $82.66
  • Rituxan (Biological) $81.64
  • Rinvoq (Biological) $74.70
  • AVSOLA (Biological) $72.57
  • Otezla (Drug) $62.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Rheumatology Doctors in Spokane